PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Data as of , from SEC Form 4 filings.
See up to 3 months of PACB. The 7-day demo opens the 1M and 3M ranges and puts PACB on your watchlist.
Start 7-day demoLatest PACB insider trades
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
- MENLO PARK, CA
- 485
- 2010
- XNAS
PACB Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 688,726 | $2.09M |
| Grant or award | 2 | 2,457,018 | |
| Option exercise | 2 | 1,000,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PACB insider transactions (Form 4)
736 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Randall S. Livingston - Director | Grant or award | Stock Option (right to buy) | 65,000 | $0.00 | - | |
| Kathy Ordonez - Director | Grant or award | Stock Option (right to buy) | 65,000 | $0.00 | - | |
| John F. Milligan - Director | Grant or award | Stock Option (right to buy) | 65,000 | $0.00 | - | |
| Michele Farmer - Officer | Open-market sale | Common Stock | 5,195 | $1.00 | $5K | |
| James R. Gibson II - Officer | Grant or award | Common Stock | 1,000,000 | $0.00 | - | |
| James R. Gibson II - Officer | Grant or award | Stock Option (right to buy) | 2,000,000 | $0.00 | - | |
| Susan G. Kim - Officer | Open-market sale | Common Stock | 19,782 | $1.72 | $34K |
Recent PACB Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Jim Gibson | Officer | 661,815 | $1.90M | View on EDGAR | |
| MARK VAN OENE | Officer | 26,911 |
PACB insider trading FAQ
What is the latest insider trade for PACB?
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) had 3 insider filings in the last 90 days, with the most recent on 2026-10-08. The full record for PACB runs to 36 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PACB stock?
No insider purchases of PACB were filed in the last 90 days.
How many insiders are selling PACB stock?
2 insider sales of PACB were filed in the last 90 days, totaling $2.09M.
Where can I see PACB SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PACB Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - James R. Gibson II view on EDGAR
- - Oene Mark van view on EDGAR
- - Oene Mark van view on EDGAR
- - Marshall Mohr view on EDGAR
- - Christopher Gibson view on EDGAR
- - Christopher M. Smith view on EDGAR
- - Hannah Valantine view on EDGAR
- - Randall S. Livingston view on EDGAR
- - William W. Ericson view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where PACB's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PACB with a 7-day demo
- PACB on your watchlist
- Every PACB Form 4 filing on record
- Up to 3 months of PACB price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
